China Universal Asset Management Company’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-127
| Closed | -$6.27K | – | 485 |
|
|
2023
Q3 | $6.27K | Buy |
127
+74
| +140% | +$3.66K | ﹤0.01% | 377 |
|
|
2023
Q2 | $4.17K | Sell |
53
-2
| -4% | -$157 | ﹤0.01% | 385 |
|
|
2023
Q1 | $4.99K | Buy |
55
+14
| +34% | +$1.27K | ﹤0.01% | 367 |
|
|
2022
Q4 | $4.86K | Buy |
41
+3
| +8% | +$355 | ﹤0.01% | 302 |
|
|
2022
Q3 | $7K | Buy |
+38
| New | +$7K | ﹤0.01% | 240 |
|